Copyright
©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 14, 2010; 16(42): 5297-5305
Published online Nov 14, 2010. doi: 10.3748/wjg.v16.i42.5297
Published online Nov 14, 2010. doi: 10.3748/wjg.v16.i42.5297
Pretreatment (n = 90) | 1 mo (n = 90) | 2 mo (n = 81) | 3 mo (n = 71) | 6 mo (n = 69) | ||||||
No | Yes | No | Yes | No | Yes | No | Yes | No | Yes | |
Coma | ||||||||||
Studied group | 60 (66.7) | 30 (33.3) | 87 (96.7) | 3 (3.3) | 72 (89) | 9 (11) | 66 (92.9) | 5 (7.1) | 63 (91.3) | 6 (8.7) |
50 patients | 50 patients | 44 patients | 34 patients | 26 patients | ||||||
Control group | 31 (62) | 19 (38) | 29 (48) | 21 (42) | 24 (54.5) | 20 (45.5) | 14 (41.2) | 20 (58.8) | 5 (19.2) | 21 (80.7) |
Hematemesis | ||||||||||
Studied group | 72 (80) | 18 (20) | 90 (100) | 0 (0) | 75 (92.6) | 6 (7.4) | 68 (95.8) | 3 (4.2) | 60 (87) | 9 (13) |
50 patients | 50 patients | 44 patients | 34 patients | 26 patients | ||||||
Control group | 35 (70) | 15 (30) | 32 (64) | 18 (36) | 24 (54.5) | 20 (54.5) | 12 (35.3) | 24 (70.6) | 6 (23) | 20 (77) |
- Citation: Salama H, Zekri ARN, Bahnassy AA, Medhat E, Halim HA, Ahmed OS, Mohamed G, Alim SAA, Sherif GM. Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease. World J Gastroenterol 2010; 16(42): 5297-5305
- URL: https://www.wjgnet.com/1007-9327/full/v16/i42/5297.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i42.5297